medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 6

<< Back Next >>

Rev Mex Pediatr 2022; 89 (6)

Quality of life in pediatric patients with terminal chronic kidney disease with hemodialysis and ambulatory peritoneal dialysis

Jáuregui-González ME, Zurita-Cruz JN, Zepeda-Martínez CC, Alegría-Torres G
Full text How to cite this article 10.35366/111688

DOI

DOI: 10.35366/111688
URL: https://dx.doi.org/10.35366/111688

Language: Spanish
References: 26
Page: 234-240
PDF size: 235.50 Kb.


Key words:

health-related quality of life, chronic kidney disease, peritoneal dialysis, hemodialysis, children, adolescents.

ABSTRACT

Introduction: chronic kidney disease (CKD) is a public health problem, and more and more children with CKD reach adulthood, requiring renal replacement therapy, which directly affects their quality of life (QoL). Objective: to compare the QoL between pediatric patients with end-stage CKD undergoing automated peritoneal dialysis (APD) and hemodialysis (HD) treatment. Material and methods: a cross-sectional study was carried out that included patients older than six years with CKD on renal replacement therapy with APD or HD for more than three months. The TECAVNER questionnaire was applied, which is a specific instrument that evaluates QoL in children with CKD. Results: of the total, 38.3% (n = 18) were classified as having good QoL. However, there was no difference between HD and DPA, since the global QoL score had a median of 3.633 and 3.379, respectively (p = 0.136). But, in the domains of physical activity and personal time, HD patients had lower scores (p < 0.05). Conclusion: only about a third of pediatric patients with CKD treated with APD or HD have a good QoL, so it seems necessary to implement strategies to improve both their physical and emotional conditions.


REFERENCES

  1. Velarde-Jurado E, Ávila-Figueroa C. Evaluación de la calidad de vida. Salud Publica Mex. 2002; 44(4): 349-361. doi: 10.1590/S0036-36342002000400009.

  2. Rebollo P, González MP, Bobes J, Saiz P, Ortega F. Interpretación de los resultados de la calidad de vida relacionada con la salud de pacientes en terapia sustitutiva de la insuficiencia renal terminal. Nefrologia. 2000; 20(5): 431-439.

  3. Vanleerberghe P, De Witte N, Claes C, Schalock RL, Verté D. The quality of life of older people aging in place: a literature review. Qual Life Res. 2017; 26(11): 2899-2907. doi: 10.1007/s11136-017-1651-0.

  4. Willadsen TG, Bebe A, Koster-Rasmussen R, Jarbol DE, Guassora AD, Waldorff FB et al. The role of diseases, risk factors and symptoms in the definition of multimorbidity - a systematic review. Scand J Prim Health Care. 2016; 34(2): 112-121. doi: 10.3109/02813432.2016.1153242.

  5. Eriksen CU, Kamstrup-Larsen N, Birke H, Helding SAL, Ghith N, Andersen JS et al. Models of care for improving health-related quality of life, mental health, or mortality in persons with multimorbidity: A systematic review of randomized controlled trials. J Multimorb Comorb. 2022; 12: 26335565221134017. doi: 10.1177/26335565221134017.

  6. Panzarino V, Lesser J, Cassani FA. Pediatric chronic kidney disease. Adv Pediatr. 2022; 69(1): 123-132. doi: 10.1016/j.yapd.2022.03.008.

  7. Esparza-Aguilar M, Ochoa-Esquivel RC, Barajas-González A, Avila-Rosas H. Mortalidad en México por enfermedad renal crónica en menores de 20 años de edad, 2000-2014. Rev Mex Pediatr. 2019; 86(2): 58-64.

  8. Quiroga B, Rodríguez-Palomares JR, De-Arriba G. Insuficiencia renal crónica. Medicine-Programa de Formación Médica Continuada Acreditado. 2015; 11(81): 4860-4867. doi: 10.1016/j.med.2015.06.004

  9. Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M et al. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease. Nefrologia. 2014; 34(3): 302-316. doi: 10.3265/Nefrologia.pre2014.Feb.12464.

  10. Torres-Toledano M, Granados-García V, López-Ocaña LR. Carga de la enfermedad renal crónica en México. Rev Med Inst Mex Seguro Soc. 2017; 55(2): S118-23.

  11. Marciano RC, Soares CM, Diniz JS, Lima EM, Silva JM, Canhestro MR et al. Mental disorders and quality of life in pediatric patients with chronic kidney disease. J Bras Nefrol. 2010; 32(3): 316-322. doi: 10.1007/s00106-003-0889-8.

  12. Aparicio-López C, Fernández-Escribano A, Garrido-Cantanero G, Luque A, Izquierdo-García E. Calidad de vida percibida por niños con enfermedad renal crónica y por sus padres. Nefrologia. 2010; 30(1): 103-109. doi: 10.3265/Nefrologia.pre2009.Dic.5683.

  13. Aparicio-López C, Fernández-Escribano A, Garrido-Cantanero G, Luque-de-Pablos A, Izquierdo-García E. Desarrollo de un cuestionario en español de medida de calidad de la vida en pacientes pediátricos con enfermedad renal crónica. Nefrologia. 2010; 30(2): 168-176. doi: 10.3265/Nefrologia.pre2009.Dic.5684.

  14. López-Soto PJ. Calidad de vida en el paciente pediátrico con enfermedad renal crónica. Enferm Nefrol. 2012; 15(4): 243-254. doi: 10.4321/S2254-28842012000400002.

  15. Brownridge B, Fielding D. An investigation of psychological factors influencing adherence to medical regime in children and adolescents undergoing haemodialysis and CAPD. Int J Adolesc Med Health. 2011; 4(1): 7-18. doi: 10.1515/IJAMH.1989.4.1.7.

  16. Goldstein SL, Graham N, Burwinkle T, Warady B, Farrah R, Varni JW. Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol. 2006; 21(6): 846-850. doi: 10.1007/s00467-006-0081-y.

  17. Buyan N, Türkmen MA, Bilge I, Baskin E, Haberal M, Bilginer Y et al. Quality of life in children with chronic kidney disease. Pediatr Nephrol. 2010; 25(8): 1487-1496. doi: 10.1007/s00467-010-1486-1.

  18. Aparicio-López C, Fernández-Escribano A, Izquierdo-García E, Luque-de-Pablos A, Garrido-Cantanero E. Medida mediante un test específico de la calidad de vida relacionada con la salud en niños con enfermedad renal crónica. Influencia del tratamiento. Nefrologia. 2010; 30(2): 177-184. doi: 10.3265/Nefrologia.pre2010.Mar.10328.

  19. El-Shafei AM, Soliman-Hegazy I, Fadel FI, Nagy EM. Assessment of quality of life among children with end-stage renal disease: a cross-sectional study. J Environ Public Health. 2018; 2018: 8565498. doi: 10.1155/2018/8565498.

  20. Alhusaini OA, Wayyani LA, Dafterdar HE, Gamlo MM, Alkhayat ZA, Alghamdi AS et al. Compari son of quality of life in children undergoing peritoneal dialysis versus hemodialysis. Saudi Med J. 2019; 40(8): 840-843. doi: 10.15537/smj.2019.8.12747.

  21. Ruidiaz-Gómez KS, Higuita-Gutiérrez LF. Impact of chronic kidney disease on health-related quality of life in the pediatric population: meta-analysis. J Pediatr (Rio J). 2021; 97(5): 478-489. doi: 10.1016/j.jped.2020.10.013.

  22. Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW et al. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics. 2010; 125(2): e349-357. doi: 10.1542/peds.2009-0085.

  23. Hansrivijit P, Chen YJ, Lnu K, Trongtorsak A, Puthenpura MM, Thongprayoon C, Bathini T, Mao MA, Cheungpasitporn W. Prediction of mortality among patients with chronic kidney disease: a systematic review. World J Nephrol. 2021; 10(4): 59-75. doi: 10.5527/wjn.v10.i4.59.

  24. Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis. 2013; 62(3): 493-505. doi: 10.1053/j.ajkd.2013.02.369.

  25. Kelly JT, Palmer SC, Wai SN, Ruospo M, Carrero JJ, Campbell KL et al. Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2017; 12(2): 272-279. doi: 10.2215/CJN.06190616.

  26. Villasís-Keever MÁ. La evaluación de la calidad de vida como parte de la atención médica en pacientes pediátricos. Rev Mex Pediatr. 2022; 89(3): 93-94. doi:10.35366/109304.




Figure 1
Table 1
Table 2
Table 3

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2022;89